These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 8579926

  • 1. Risedronate pretreatment does not hamper the anabolic effects of prostaglandin E2 in ovx rats.
    Li QN, Jee WS, Ma YF, Ke HZ, Xie H, Huang LF, Liang NC.
    Bone; 1995 Oct; 17(4 Suppl):261S-266S. PubMed ID: 8579926
    [Abstract] [Full Text] [Related]

  • 2. Intermittent treatment of prostaglandin E2 with risedronate is more anabolic than prostaglandin E2 alone in the proximal tibial metaphysis of ovariectomized rats.
    Chen HK, Jee WS, Ma YF, Pan Z, McOsker JE, Li XJ.
    Bone; 1995 Oct; 17(4 Suppl):285S-289S. PubMed ID: 8579930
    [Abstract] [Full Text] [Related]

  • 3. Intermittent treatments of prostaglandin E2 plus risedronate and prostaglandin E2 alone are equally anabolic on tibial shaft of ovariectomized rats.
    Pan Z, Jee WS, Ma YF, McOsker JE, Li XJ.
    Bone; 1995 Oct; 17(4 Suppl):291S-296S. PubMed ID: 8579931
    [Abstract] [Full Text] [Related]

  • 4. Risedronate plus prostaglandin E2 is superior to prostaglandin E2 alone in maintaining the added bone after withdrawal in a non-growing bone site in ovariectomized rats.
    Liang HH, Ma YF, Jee WS, Pan Z, Setterberg RB, McOsker JE, Li XJ.
    Bone; 1995 Oct; 17(4 Suppl):335S-339S. PubMed ID: 8579936
    [Abstract] [Full Text] [Related]

  • 5. Co-treatment of PGE2 and risedronate is better than PGE2 alone in the long-term treatment of ovariectomized-induced osteopenic rats.
    Ma Y, Chen YY, Jee WS, Ke HZ, Ijiri K.
    Bone; 1995 Oct; 17(4 Suppl):267S-272S. PubMed ID: 8579927
    [Abstract] [Full Text] [Related]

  • 6. Intermittent on/off prostaglandin E2 and risedronate are equally anabolic as daily PGE2 alone treatment in cortical bone of ovariectomized rats.
    Ma YF, Pan Z, Jee WS, Lin CH, Liang HH, Chen H, Pun S, Li XJ.
    J Bone Miner Res; 1997 Dec; 12(12):2108-12. PubMed ID: 9421244
    [Abstract] [Full Text] [Related]

  • 7. Prostaglandin E2 (PGE2) and risedronate was superior to PGE2 alone in maintaining newly added bone in the cortical bone site after withdrawal in older intact rats.
    Ma YF, Lin BY, Jee WS, Lin CH, Chen YY, Ke HZ, Li XJ.
    J Bone Miner Res; 1997 Feb; 12(2):267-75. PubMed ID: 9041060
    [Abstract] [Full Text] [Related]

  • 8. Effects of prostaglandin E2 and risedronate administration on cancellous bone in older female rats.
    Lin BY, Jee WS, Ma YF, Ke HZ, Kimmel DB, Li XJ.
    Bone; 1994 Feb; 15(5):489-96. PubMed ID: 7980959
    [Abstract] [Full Text] [Related]

  • 9. Skeletal effects of constant and terminated use of risedronate on cortical bone in ovariectomized rats.
    Li QN, Liang NC, Huang LF, Wu T, Hu B, Mo LE.
    J Bone Miner Metab; 1999 Feb; 17(1):18-22. PubMed ID: 10084397
    [Abstract] [Full Text] [Related]

  • 10. Prostaglandin E2 increased rat cortical bone mass when administered immediately following ovariectomy.
    Ke HZ, Jee WS, Zeng QQ, Li M, Lin BY.
    Bone Miner; 1993 Jun; 21(3):189-201. PubMed ID: 8400919
    [Abstract] [Full Text] [Related]

  • 11. Effect of pre- and post-surgery treatment with risedronate on trabecular bone loss in ovariectomized rats.
    Iwamoto J, Takeda T, Sato Y, Shen CL, Yeh JK.
    Exp Anim; 2006 Oct; 55(5):457-66. PubMed ID: 17090962
    [Abstract] [Full Text] [Related]

  • 12. Extra cancellous bone induced by combined prostaglandin E2 and risedronate administration is maintained after their withdrawal in older female rats.
    Jee WS, Lin BY, Ma YF, Ke HZ.
    J Bone Miner Res; 1995 Jun; 10(6):963-70. PubMed ID: 7572321
    [Abstract] [Full Text] [Related]

  • 13. Beneficial effect of pretreatment and treatment continuation with risedronate and vitamin K2 on cancellous bone loss after ovariectomy in rats: a bone histomorphometry study.
    Iwamoto J, Takeda T, Sato Y, Shen CL, Yeh JK.
    J Nutr Sci Vitaminol (Tokyo); 2006 Oct; 52(5):307-15. PubMed ID: 17190100
    [Abstract] [Full Text] [Related]

  • 14. Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats.
    Baumann BD, Wronski TJ.
    Bone; 1995 Feb; 16(2):247-53. PubMed ID: 7756054
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Maintaining restored bone with bisphosphonate in the ovariectomized rat skeleton: dynamic histomorphometry of changes in bone mass.
    Jee WS, Tang L, Ke HZ, Setterberg RB, Kimmel DB.
    Bone; 1993 Feb; 14(3):493-8. PubMed ID: 8363898
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic effect of risedronate on cancellous and cortical bone in ovariectomized osteopenic rats: a comparison with the effects of alfacalcidol.
    Iwamoto J, Seki A, Takeda T, Sato Y, Yamada H, Yeh JK.
    Exp Anim; 2006 Jul; 55(4):333-42. PubMed ID: 16880680
    [Abstract] [Full Text] [Related]

  • 19. Prostaglandin E2 prevents ovariectomy-induced cancellous bone loss in rats.
    Ke HZ, Li M, Jee WS.
    Bone Miner; 1992 Oct; 19(1):45-62. PubMed ID: 1422305
    [Abstract] [Full Text] [Related]

  • 20. Effects of prostaglandin E2 and F2 alpha on the skeleton of osteopenic ovariectomized rats.
    Ma YF, Li XJ, Jee WS, McOsker J, Liang XG, Setterberg R, Chow SY.
    Bone; 1995 Dec; 17(6):549-54. PubMed ID: 8835309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.